GlaxoSmithKline in $105 mln settlement with U.S. states over marketing
June 04, 2014 at 13:02 PM EDT
June 4 (Reuters) - British drugmaker GlaxoSmithKline Plc has agreed to pay $105 million to settle allegations by 44 U.S. states and the District of Columbia that it promoted its medicines for unapproved uses, several states attorneys general announced on Wednesday.